ARTICLE | Company News
Elan, Solstice deal
July 12, 2004 7:00 AM UTC
ELN sold the worldwide rights for Myobloc/ Neurobloc to Solstice Neurosciences. Myobloc is an injectable solution of botulinum toxin Type B to reduce the severity of abnormal head position and neck p...